PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of oximedOxidative Medicine and Cellular Longevity
 
Oxid Med Cell Longev. 2017; 2017: 3793817.
Published online 2017 February 9. doi:  10.1155/2017/3793817
PMCID: PMC5322428

Resveratrol Attenuates Copper-Induced Senescence by Improving Cellular Proteostasis

Abstract

Copper sulfate-induced premature senescence (CuSO4-SIPS) consistently mimetized molecular mechanisms of replicative senescence, particularly at the endoplasmic reticulum proteostasis level. In fact, disruption of protein homeostasis has been associated to age-related cell/tissue dysfunction and human disorders susceptibility. Resveratrol is a polyphenolic compound with proved antiaging properties under particular conditions. In this setting, we aimed to evaluate resveratrol ability to attenuate cellular senescence induction and to unravel related molecular mechanisms. Using CuSO4-SIPS WI-38 fibroblasts, resveratrol is shown to attenuate typical senescence alterations on cell morphology, senescence-associated beta-galactosidase activity, and cell proliferation. The mechanisms implicated in this antisenescence effect seem to be independent of senescence-associated genes and proteins regulation but are reliant on cellular proteostasis improvement. In fact, resveratrol supplementation restores copper-induced increased protein content, attenuates BiP level, and reduces carbonylated and polyubiquitinated proteins by autophagy induction. Our data provide compelling evidence for the beneficial effects of resveratrol by mitigating CuSO4-SIPS stressful consequences by the modulation of protein quality control systems. These findings highlight the importance of a balanced cellular proteostasis and add further knowledge on molecular mechanisms mediating resveratrol antisenescence effects. Moreover, they contribute to identifying specific molecular targets whose modulation will prevent age-associated cell dysfunction and improve human healthspan.

1. Introduction

Normal somatic dividing cells have been proved to be valuable in vitro models to study cellular senescence and unravel molecular mechanisms and pathways implicated in the human aging process. The well-known model of replicative senescence (RS) is achieved when human diploid fibroblasts (HDFs) spontaneously stop dividing after an initial active period of population doublings and become unresponsive to mitogenic stimuli [1]. Besides the irreversible cell cycle arrest, RS fibroblasts exhibit other typical, morphological, and molecular features, such as increased cellular volume, higher senescence-associated beta-galactosidase (SA beta-gal) activity, and increased expression of senescence-associated genes and proteins [2, 3]. A similar senescent phenotype, termed stress-induced premature senescence (SIPS), can be attained by the exposure of HDFs to subcytotoxic doses of oxidative stress inducers such as hydrogen peroxide (H2O2-SIPS) [4], tert-butyl hydroperoxide, ultraviolet B radiation [3], or copper sulfate (CuSO4-SIPS) [5]. Recently, the latter was shown to mimic better the RS model compared to the most frequently used H2O2-SIPS model [6].

Resveratrol is a natural polyphenolic compound that was shown to increase maximum lifespan of several organisms, such as Saccharomyces cerevisiae [7], Caenorhabditis elegans [8], Drosophila melanogaster [9], and the short-lived fish Nothobranchius furzeri [10]. Yet, resveratrol failed to extend longevity in rodent mammals, even though it improved their healthspan, thus evidencing a protective role against age-related deterioration [11].

At the cellular level, resveratrol has also been shown to attenuate senescence features in either RS [12] or H2O2-SIPS [13, 14] cellular models. These antiaging effects have long been associated with resveratrol ability to activate sirtuin 1 deacetylase, Sirt1 [for a review see [15]]. Actually, it was demonstrated that Sirt1 overexpression attenuates senescence and extends replicative lifespan of several cultured cell types [1618], while its inhibition results in increased cellular senescence [16]. Also, Sirt1 was shown to be downregulated with aging [19] and in cellular senescence models [20, 21] further favoring its preventive role of senescence features. Besides resveratrol ability to modulate signal transduction pathways through the activation of Sirt1 [14, 22], several other biological events were assigned as responsible for its positive effects, including its ability to increase stress resistance [12], to induce telomerase activity [23], to decrease the secretion of senescence-associated proinflammatory proteins [24], and to inhibit the mechanistic target of rapamycin, mTOR [13]. Resveratrol was also found to modulate protein quality control cellular responses, as it was shown to regulate the expression of the heat shock molecular chaperones [25] and to promote cellular protein degradation mechanisms, namely, ubiquitin-proteasome system (UPS) [26, 27] and lysosomal autophagy [28, 29]. Moreover, resveratrol was able to increase C. elegans lifespan through the upregulation of abu11 (activated in blocked unfolded protein response-11), which encodes a protein involved in the endoplasmic reticulum (ER) unfolded protein response (UPR) that protects the organism from damage by improperly folded proteins [8].

In the present study we aimed to evaluate the ability of resveratrol to attenuate the establishment of cellular senescence upon CuSO4 induction, unravelling the molecular mechanisms that might be involved. It was found that resveratrol supplementation was able to reduce the appearance of some senescence-associated features by the improvement of cellular proteostasis probably by protecting proteins from oxidative damage and preventing their accumulation by the induction of protein degradation mechanisms.

2. Material and Methods

2.1. Cell Culture

WI-38 human fetal lung fibroblasts were purchased from The European Collection of Cell Cultures (ECACC) and were cultivated in complete medium composed of Basal Medium Eagle (BME) supplemented with 10% fetal bovine serum, at 37°C in a 5% CO2 humidified atmosphere. WI-38 cells are considered to be young below 30 population doublings (PDs) and enter senescence at 45 PDs or above. For the induction of SIPS with copper sulfate (CuSO4-SIPS), subconfluent young WI-38 fibroblasts were exposed to 350 μM CuSO4 (Na2SO4 for controls) for 24 h. Then, cells were washed once with phosphate buffered saline (PBS) and replaced with fresh complete medium containing 5 or 10 μM of resveratrol (R5010-Sigma-Aldrich®) for an additional 72 h period. Control cells were submitted to a final concentration of 0.1% DMSO for the same period.

2.2. Cell Morphology and SA Beta-Gal Detection

Cell morphology evaluation was performed 72 h after copper removal by optical inspection using an inverted microscope. To assess the presence of senescent cells, SA beta-gal was detected 72 h after copper removal as already described [5]. The percentage of SA beta-gal positive cells in each condition was determined by microscopically counting 400 total cells/well from at least three independent experiments.

2.3. Cell Proliferation and Total Protein Content

To assess the effect of the different treatments on cell proliferation and total protein content, cell number determination and SRB assay [30] were performed along time after copper removal. Briefly, 3000 cells/well were seeded in 96-well culture plates, treated for 24 h with CuSO4 (or Na2SO4 for controls), and then analyzed at different time-points (0, 24, 48, and 72 h) while recovering in the presence or absence of resveratrol. For cell number determination, cells were trypsinized and stained with Trypan Blue, and the viable cells were microscopically counted in a Neubauer chamber. The total number of cells per well for each condition at the different time-points was calculated and plotted, assuming that, at t = 0, for each condition, cell number equals 1. For the total protein content determination, cells were treated with 10% trichloroacetic acid (TCA), 1 hour at 4°C. The TCA-precipitated proteins fixed at the bottom of the wells were stained for 30 minutes with 0.057% (w/v) SRB in 1% acetic acid solution and then washed four times with 1% acetic acid. Bound dye was solubilized with 10 mM Tris base solution and the absorbance at 510 nm of each well was recorded using a microplate reader (Infinite 200, TECAN).

2.4. Real Time PCR

Gene expression experiments were performed 72 h after copper sulfate treatment by real time quantitative PCR (qPCR). Total RNA extracted (PureLink® RNA Mini Kit, Ambion) from cells derived from at least three independent cultures from each condition was converted into cDNA by reverse transcription reaction. Amplification reaction assays contained SYBR Green Mastermix (SYBR® Select Master Mix, Applied Biosystems®), 50 ng cDNA and primers (STAB VIDA, Lda.) at optimal concentrations. The primer sequences were p21, 5′-CTGGAGACTCTCAGGGTCGAA-3′ and 5′-CCAGGACTGCAGGCTTCCT-3′; ApoJ, 5′-GGATGAAGGACCAGTGTGACAAG-3′ and 5′-CAGCGACCTGGAGGGATTC-3′; TGFβ1, 5′-AGGGCTACCATGCCAACTTCT-3′ and 5′-CCGGGTTATGCTGGTTGTACA-3′; and TATA box binding protein (TBP), 5′-TCAAACCCAGAATTGTTCTCCTTAT-3′ and 5′-CCTGAATCCCTTTAGAATAGGGTAGA-3′. The protocol used for qPCR was 95°C (3 min); 40 cycles of 95°C (15 sec); and 60°C (1 min). qPCR was performed in the StepOnePlus™ thermal cycler (Applied Biosystems™). TBP was the selected housekeeping gene when calculating relative transcript levels of the target genes.

2.5. Western Blot

Protein levels were assessed 72 h after copper sulfate exposure by western blot analysis. WI-38 cells submitted to the different treatments were washed with PBS and scrapped on ice in a lysis buffer (10 mM Tris, pH 7.4, 100 mM NaCl, 1 mM EDTA, 0.1% Triton X-100) supplemented with protease inhibitors cocktail (Sigma-Aldrich). Upon Bradford assay, 20 μg (or 10 μg for the detection of carbonylated or poly-Ub proteins) of protein from each cell extract was resolved by SDS-PAGE. Proteins were blotted into a nitrocellulose membrane and, after blocking with 5% nonfat dry milk diluted in Tris-buffered saline 0.1% tween 20 (TBST), were probed with specific primary antibodies (anti-HSP90 ab13495 and anti-p62 ab109012, Abcam®; anti-LC3 NB100-2220, Novus Biologicals; anti-ubiquitin PW0930, Enzo® Life Sciences; anti-p21 #2946, anti-phospho-eIF2 #3398, anti-HSP70 #4876, and anti-BiP #3177, Cell Signaling Technology®) overnight at predetermined optimal dilutions. For the specific detection of carbonylated proteins, immediately after protein transfer, the nitrocellulose-bound proteins were treated as described elsewhere [31]. Briefly, the membranes were equilibrated in 20% methanol in TBS, washed for 5 min with 10% trifluoroacetic acid (TFA), derivatized with 5 mM 2,4-dinitrophenylhydrazine (DNPH, Sigma-Aldrich) diluted in 10% TFA for 10 min (protected from light), washed with 10% TFA to remove the excess of DNPH, and finally washed with 50% methanol. Following this procedure, the membranes were blocked with 5% bovine serum albumin in TBST and incubated with primary anti-DNP antibody (D9656, Sigma-Aldrich). From here on, the western blot procedure was similar to all antibodies: after TBST washing, immunoblots were incubated with the appropriate peroxidase-conjugated secondary antibodies for 1 h, detected using ECL western blotting substrate (Pierce™, Thermo Scientific) and visualized in ChemiDocTM XRS (BioRad Laboratories). Results were quantified by densitometry using the Image Lab® software. Protein loading was normalized using Ponceau S protein staining, but similar data were also obtained using tubulin detection (data not shown).

2.6. Statistical Analysis

Student's t-test was used to compare the means between two different conditions. A p value lower than 0.05 was considered statistically significant.

3. Results

3.1. Sirtuin 1 Expression Is Diminished in CuSO4-SIPS

It was already demonstrated that Sirt1 expression decreases with increasing population doublings [20] and also in H2O2-SIPS cellular models [21]. Here, Sirt1 transcript and protein levels were evaluated by qPCR and western blot, respectively, in CuSO4-induced senescent WI-38 fibroblasts. Similarly to other RS and SIPS models, CuSO4-SIPS fibroblasts also presented decreased expression of both gene (Figure 1(a)) and protein (Figure 1(b)) Sirt1. Namely, mRNA and protein relative level presented a 27% and 23% reduction, respectively, in copper-treated cells when compared to controls (p = 0.04 and p = 0.008, resp.). The effect of resveratrol (5 or 10 μM), a Sirt1 activator, was evaluated 72 h after the 24 h incubation of cells with CuSO4, which is the usual recovery time that cells need to adapt and develop the senescent phenotype [5]. The addition of 10 μM resveratrol attenuated the copper-induced decrease in Sirt1 protein levels (p = 0.047) to values similar to the young control cells. Incubation of non-CuSO4 submitted fibroblasts with 5 and 10 μM resveratrol for 72 h increased Sirt1 protein level by 1.6- and 1.3-fold (p = 0.008 and p = 0.01), respectively, when compared to young control cells (Figure 1(b)).

Figure 1
Reduced sirtuin 1 expression in CuSO4-SIPS fibroblasts is restored by the addition of resveratrol. (a-b) WI-38 fibroblasts were incubated with 350 µM CuSO4 (or Na2SO4, for controls) for 24 h. Then, media were changed and cells ...

3.2. Resveratrol Attenuates the Appearance of Some Typical Senescence-Associated Alterations

Senescent cells usually present typical morphological alterations, increased level of SA beta-gal, and irreversible inhibition of cell proliferation. Therefore, these three features were evaluated in order to assess the effect of resveratrol in CuSO4-SIPS fibroblasts. Briefly, cell proliferation was assessed by counting the viable cells at 0, 24, 48, and 72 h after copper removal. Then, at the last time-point (72 h), cell morphology was observed and the percentage of SA beta-gal positive cells was quantified for each condition. As shown in Figure 2(a), in the absence of resveratrol, CuSO4-SIPS fibroblasts presented the typical senescent morphology, as they were no longer small and fusiform and became enlarged and flattened. However, copper-treated cells recovering in the presence of resveratrol exhibited less pronounced senescent-like alterations, as they appeared thinner and more elongated, when compared to cells in the absence of resveratrol. This was particularly evident for the highest concentration of resveratrol used (10 μM). It is noteworthy to mention that even cells not submitted to copper exhibited a slightly different aspect in the presence of resveratrol, as they seemed smaller and their cell limits were more clear-cut.

Figure 2
Resveratrol attenuates the appearance of typical senescence-associated features induced by CuSO4. (a) Cell morphology was evaluated 72 h after the removal of 350 µM CuSO4 (or Na2SO4, for controls) in fibroblasts that were allowed ...

Similar to previously reported results [6], CuSO4-SIPS cellular model contained 34% of cells positive for SA beta-gal (Figure 2(b)), whereas the controls had only 5% of senescent cells. However, the addition of 5 and 10 μM resveratrol to copper-treated cells resulted in a statistically significant reduction in the number of SA beta-gal positive cells (to 16 and 14%, resp.). The ability of copper sulfate to inhibit cell proliferation had previously been described [6] and herein is again demonstrated (Figure 2(c)), as 3 days after stress, copper-treated cells presented a reduction of 88% in their proliferation when compared to controls. Media supplementation with 5 and 10 μM resveratrol during the recovery period resulted in the attenuation of cell proliferation inhibition by 20 and 34%, respectively. In addition, in the absence of copper, the selected concentrations of resveratrol were not able to affect significantly cell proliferation when compared to control cells. Altogether, these data show that resveratrol can actually attenuate the induction of senescence by copper sulfate in WI-38 fibroblasts.

3.3. Resveratrol Does Not Alter Copper-Induced Upregulation of Senescence-Associated Genes and Proteins

There are several genes and proteins, such as the cyclin-dependent kinase inhibitor 1A (p21), apolipoprotein J (ApoJ), and transforming growth factor beta 1 (TGFβ1), whose overexpression is typical of the senescent phenotype observed in RS and SIPS cellular models. Herein, we evaluated the ability of resveratrol to adjust the levels of p21, ApoJ, and TGFβ1 upon copper treatment, in order to justify its effect in the attenuation of copper-induced senescence. Therefore, the mRNA transcript relative levels of these genes were quantified by qPCR (Figure 3(a)). In accordance with previous publication [5], p21, ApoJ, and TGFβ1 mRNA levels were found upregulated by 2.2-, 1.6-, and 1.6-fold, respectively, in CuSO4-SIPS fibroblasts when compared to control cells. However, the addition of resveratrol (either 5 or 10 μM) immediately after copper sulfate removal did not have any statistically significant effect on the transcript levels of these genes. To validate these results and exclude the occurrence of posttranslational regulation, the relative protein levels of p21 and ApoJ were evaluated by western blot (Figure 3(b)). At the protein level, p21 and ApoJ presented a 3.2- and 1.8-fold increase in copper-treated cells, when compared to controls, thus confirming the previously noticed trend. In addition, similarly to transcript levels results, resveratrol supplementation did not affect copper-induced augmentation of these proteins. Overall, the effect of resveratrol in the attenuation of copper-induced senescence does not involve the regulation of p21, ApoJ, and TGFβ1 senescence-associated genes.

Figure 3
Resveratrol supplementation does not affect copper-induced expression of senescence-associated molecules. (a) Transcript relative levels of cyclin-dependent kinase inhibitor 1A (p21), apolipoprotein J (ApoJ), and transforming growth factor beta 1 (TGF ...

3.4. CuSO4-Induced Proteostasis Imbalance Is Attenuated by Resveratrol

The occurrence of proteostasis imbalance is a major hallmark of aging [32] and, at the cellular level, may be shown by increased intracellular protein content [33]. To measure cellular protein accumulation for each experimental condition, the ratio between total protein content and cell number, here defined as the protein load index (PLI), was calculated at 0, 24, 48, and 72 h after CuSO4 removal (sodium sulfate for controls). Assuming that immediately after stress removal PLI equals 1, it was shown that it significantly increased 1.7-fold at 48 and 72 h time-points in CuSO4-SIPS cells when compared to the respective control conditions (Figure 4). CuSO4-treated fibroblasts that were allowed to recover in the presence of 5 μM resveratrol exhibited a statistically significant 0.5-fold decrease in PLI at 48 h, when compared with cells without added resveratrol. Moreover, the addition of 10 μM resveratrol after copper removal totally reverted PLI to the level of controls in the absence of copper at 48 h and presented a statistically significant 0.5-fold decrease at 72 h, when compared to copper-treated cells in the absence of resveratrol at the same time-point.

Figure 4
CuSO4-induced proteostasis imbalance is attenuated by resveratrol. Protein load index (PLI), used as a measure of cellular protein accumulation, was calculated as the ratio between total protein content and cell number for each condition, at different ...

To compensate the altered proteostasis, CuSO4-SIPS cells present higher levels of phosphorylated eukaryotic translation initiation factor 2 (p-eIF2) [6], which inhibits general protein translation and allows cells to restore homeostasis. A possible explanation for the diminished PLI obtained for copper cells recovering in the presence of resveratrol could be an increased inhibition of overall protein synthesis caused by higher p-eIF2. When p-eIF2 was quantified by western blot (Figure 5(a)), as expected it was found increased in CuSO4-treated cells, compared to controls. However, resveratrol supplementation upon copper removal did not result in any additional alteration in p-eIF2 protein level. Next, cell chaperoning ability was evaluated by the quantification of the molecular chaperones immunoglobulin binding protein (BiP), heat shock protein (HSP) 90, and HSP70 by western blot (Figure 5(b)). In fact, the intracellular protein levels of BiP, HSP90, and HSP70 were 1.4-, 1.9-, and 6.3-fold increase in CuSO4-SIPS fibroblasts, when compared to control cells. The presence of resveratrol after copper removal had no effect on HSP90 and HSP70 protein levels comparing to the levels of copper-treated cells without resveratrol. However, BiP protein levels were diminished (to 1.1-fold) in copper-treated cells that were allowed to recover in the presence of 10 μM resveratrol, relatively to the condition without resveratrol, reflecting a lower need to buffer defective or damaged proteins.

Figure 5
Resveratrol attenuates copper-induced BiP upregulation but has no effect on eIF2 phosphorylation or HSP90 and HSP70 expression. (a) Phosphorylated eukaryotic translation initiation factor 2 (p-eIF2) and (b) immunoglobulin binding protein (BiP), heat shock ...

3.5. Resveratrol Attenuates CuSO4-Induced Accumulation of Modified Proteins by the Induction of Lysosomal Autophagy

The altered proteostasis observed in CuSO4-SIPS fibroblasts could be a consequence of a progressive accumulation of oxidatively modified proteins. Protein carbonylation is a type of irreversible protein oxidation that is frequently used as an indicator of increased permanent levels of oxidative stress. Actually, cellular senescence models [34] and cells treated with oxidative stress inducers [35] were both shown to exhibit increased levels of carbonylated proteins. Herein, carbonyl protein content was evaluated to infer about cellular oxidative status in the different experimental conditions. CuSO4-SIPS cells presented a statistically significant 13% increase (p = 0.0017) in the relative levels of carbonylated proteins, when compared to control cells (Figure 6(a)). The addition of 10 μM resveratrol during cell recovery (but not 5 μM) was able to attenuate such increase in protein oxidation by 34%, a variation that was close to reach statistical significance (p = 0.054). These data suggest that resveratrol may be able to prevent or attenuate the accumulation of copper-induced oxidized proteins. This may be achieved either by its well described antioxidant properties that might prevent protein damage or by its ability to modulate protein degradation processes. UPS activity is known to be reduced during aging. The accumulation of polyubiquitinated (poly-Ub) proteins is usually associated with decreased UPS efficiency and, in fact, here a 22% increase in the levels of poly-Ub proteins in CuSO4-SIPS fibroblasts was observed (Figure 6(b)). In addition, resveratrol supplementation (only at 10 μM) immediately after copper sulfate removal showed to be effective on restoring poly-Ub protein levels to the control cells ones, in a statistically significant manner (p = 0.026).

Figure 6
CuSO4-induced accumulation of carbonylated and polyubiquitinated proteins is reduced by resveratrol, through lysosomal autophagy induction. (a) Protein carbonyl content and (b) polyubiquitinated (poly-Ub) proteins were evaluated in fibroblasts submitted ...

Depending on the conformation of the polyubiquitin chain that they possess, poly-Ub proteins may be degraded either in the proteasome or by lysosomal macroautophagy [36], mentioned as autophagy from here on in order to simplify. Autophagy plays a crucial role in the recycling of dysfunctional organelles and damaged protein aggregates and it was shown to be induced by resveratrol in order to prevent oxidative stress cellular damage [28, 29]. In the present study, the induction of autophagy was evaluated by the conversion of LC3-I to LC3-II, an essential step for autophagosome formation, by calculating the ratio of the LC3-II/LC3-I protein levels using western blot. Furthermore, the level of P62 protein, an ubiquitin-binding protein that serves as a link between LC3 and Ub substrates during autophagosome formation was also evaluated by western blot technique (Figure 6(c)). CuSO4-SIPS cells presented a statistically significant 1.4-fold increase in LC3-II/LC3-I ratio, when compared to young control fibroblasts. Furthermore, cell treatment with 10 μM resveratrol after copper removal further increased this ratio (to 1.8-fold, p = 0.017), when compared to copper-treated cells that were allowed to recover in the absence of resveratrol. Accordingly, P62 protein levels were increased by 1.5-fold in CuSO4-SIPS, when compared to control. Moreover, exposure to 10 μM resveratrol after copper removal resulted in additional increase in P62 protein expression (to 1.9-fold, p = 0.039).

4. Discussion

The CuSO4-SIPS cellular model has proven to have major value for studying molecular events that are responsible for the aging process [5, 6, 37]. Furthermore, it brought additional evidence supporting copper contribution to the age-related functional deterioration and to the progression of age-related disorders. The present study shows that CuSO4-induced cell senescence results in reduced Sirt1 expression. As Sirt1 is activated by the polyphenolic compound resveratrol, the mechanism and possibility of attenuating this senescent effect upon Sirt1 were addressed. In fact, it was demonstrated that resveratrol supplementation attenuated copper-induced appearance of some typical senescence features. In addition, the mechanism behind such antisenescence effect of resveratrol was shown to involve the modulation of cellular proteostasis either by the protection of proteins from oxidative damage or by the induction of protein degradation processes.

The effect of resveratrol on cellular senescence has been investigated, but the results are contradictory: while some authors reported resveratrol ability to attenuate cellular aging [1214], others showed that it induced the appearance of senescence [3841]. In either case, the molecular mechanisms involved in such effects were not fully clear. We believe that this discrepancy is explained by the different experimental conditions utilized in these studies: resveratrol ability to induce cell senescence was often reported using tumor cell lines [3840] treated with high concentrations of the compound (above 25 μM) that in some cases resulted in pro-apoptotic effects [41]; in turn, antiaging effects were described in nontumor cell lines, incubated with lower doses of resveratrol [12]. In line with these evidences, herein, the administration of 5 or 10 μM resveratrol immediately after copper sulfate removal was able to attenuate the induction of WI-38 fibroblast cellular senescence, as the percentage of SA beta-gal positive cells was decreased, the typical morphological alterations were less evident, and the blockage of cell cycle was alleviated. However, in this study, resveratrol was not able to attenuate copper-induced upregulation of senescence-associated molecules, such as p21, ApoJ, and TGFβ1. This indicates that the mechanism behind the positive antisenescence effects of resveratrol does not involve the inhibition of copper-induced expression of such senescence-associated genes.

It was recently reported that both RS and CuSO4-SIPS models exhibit altered expression of several ER molecular chaperones and enzymes and activated ER UPR pathways [6]. Here, CuSO4-SIPS fibroblasts exhibited greater total protein content, as measured by augmented PLI, increased expression of BiP, HSP70, and HSP90 molecular chaperones, a rise on the levels of carbonylated proteins, and higher amount of polyubiquitinated proteins, adding further evidence to the occurrence of proteostasis disruption during senescence. Nevertheless, our hypothesis that increased PLI reflects impaired proteostasis could be further supported by experimental evidence obtained for instance after inhibiting protein degradation mechanisms such as autophagy or the UPS. At present, the actual underlying molecular conditions triggering PLI increase are still unknown, but involvement of the typical cell enlargement associated with the senescence phenotype, or other mechanisms apart from proteostasis disruption, cannot be excluded. CuSO4-SIPS fibroblasts that were allowed to recover in the presence of resveratrol presented improved cellular proteostasis, as their total protein levels were similar to controls, BiP chaperone expression was attenuated, and poly-ubiquitinated proteins level was reduced. Altogether, these data demonstrated that, in the presence of resveratrol, cells were able to circumvent copper-induced disruption of cellular proteostasis, intimately related to the appearance of the typical senescent phenotype.

The well documented antioxidant properties of resveratrol are the likely contributors to this cell proteostasis maintenance effect, as it can protect proteins from being oxidized in a concentration and time-dependent manner. In fact, using in vitro oxidative stressed erythrocytes, resveratrol ability to prevent protein oxidation reaches a maximum protective effect between 30 and 60 minutes after polyphenolic compound addition and is then slightly reduced with time [42]. In the current study, resveratrol supplementation for 72 h attenuated the amount of carbonylated proteins on copper-treated cells in a variation that was close to reach statistical significance. A time-course evaluation of protein carbonylation along these 72 h should add further information on the existence of time-dependent variations on resveratrol efficiency to protect proteins from oxidation.

Another important resveratrol contribution for the modulation of cellular proteostasis is its ability to regulate protein degradation mechanisms, such as the UPS [26, 27] or lysosomal autophagy [28, 29]. Both mechanisms were shown to be intimately related as autophagy is activated to compensate UPS inhibition [43]. In brief, autophagy is crucial to degrade dysfunctional organelles and damaged protein aggregates and involves the formation of autophagosomes that are targeted to lysosomes for the degradation of their inner content. Autophagosome formation occurs in successive stages that depend on the concerted action of several proteins [44]. The cytosolic soluble protein LC3-I is particularly important in this process because it is lipidated to originate LC3-II, which integrates the autophagosome membrane. As such conversion is essential for elongation and maturation of the autophagosomes, LC3-II/LC3-I ratio is usually used to detect autophagy activation. In addition, as P62 protein is crucial to target poly-Ub-substrates into autophagosomes through LC3 binding [44], its detection further indicates such activation. Here, CuSO4-SIPS cells exhibited an increase both in LC3-I to LC3-II conversion and in P62 protein levels; when allowed to recover in the presence of resveratrol, LC3-II/LC3-I ratio and P62 protein levels were even higher, indicating an enhanced induction of autophagy and targeting of poly-Ub-substrates to autophagy. These results are in agreement with previous in vitro [45] and in vivo [28] studies demonstrating that oxidative stress conditions promote LC3-II/LC3-I ratio increase, further enhanced in the presence of resveratrol. Moreover, resveratrol has recently been described as able to promote the flux of proteins through the autophagosomal-lysosomal pathway, thus attenuating the dysfunctional effect of intracellular accumulation of damaged or defective proteins [27]. This promotion is in agreement with the results of the current study that favor resveratrol antisenescence effect as a consequence of its ability to improve cellular proteostasis through autophagy induction. However, the present study has some limitations regarding the actual induction of autophagy by resveratrol; further functional studies monitoring autophagosome number and the autophagic flux [46] in the presence of resveratrol, would clarify its effect on such processes. Moreover, given the proven crosstalk between autophagy and proteasomal degradation [47], we cannot exclude, in addition, the beneficial effects resulting from resveratrol ability to modulate the ubiquitin-proteasome system.

5. Conclusions

This study demonstrates that resveratrol is able to attenuate the induction of cell senescence resulting from CuSO4 exposure. Such effects result from resveratrol ability to promote cellular adaptive mechanisms, as autophagy upregulation, which sustain cellular proteostasis and confer cellular resistance to stress. Cellular proteostasis maintenance was found to be crucial to prevent the development of the senescent phenotype. These data also uncover molecular targets whose modulation is likely to prevent age-associated cell and tissue function deterioration and improve human healthspan.

Acknowledgments

Liliana Matos was supported by Ph.D. fellowship SFRH/BD/61820/2009 from Programa Operacional Ciência e Inovação 2010, Fundo Social Europeu, and Fundação para a Ciência e Tecnologia.

Competing Interests

The authors declare that they have no competing interests.

References

1. Hayflick L., Moorhead P. S. The serial cultivation of human diploid cell strains. Experimental Cell Research. 1961;25(3):585–621. doi: 10.1016/0014-4827(61)90192-6. [PubMed] [Cross Ref]
2. Dimri G. P., Lee X., Basile G., et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proceedings of the National Academy of Sciences of the United States of America. 1995;92(20):9363–9367. doi: 10.1073/pnas.92.20.9363. [PubMed] [Cross Ref]
3. Debacq-Chainiaux F., Pascal T., Boilan E., Bastin C., Bauwens E., Toussaint O. Screening of senescence-associated genes with specific DNA array reveals the role of IGFBP-3 in premature senescence of human diploid fibroblasts. Free Radical Biology and Medicine. 2008;44(10):1817–1832. doi: 10.1016/j.freeradbiomed.2008.02.001. [PubMed] [Cross Ref]
4. Chen Q., Ames B. N. Senescence-like growth arrest induced by hydrogen peroxide in human diploid fibroblast F65 cells. Proceedings of the National Academy of Sciences of the United States of America. 1994;91(10):4130–4134. doi: 10.1073/pnas.91.10.4130. [PubMed] [Cross Ref]
5. Matos L., Gouveia A., Almeida H. Copper ability to induce premature senescence in human fibroblasts. Age. 2012;34(4):783–794. doi: 10.1007/s11357-011-9276-7. [PMC free article] [PubMed] [Cross Ref]
6. Matos L., Gouveia A. M., Almeida H. ER stress response in human cellular models of senescence. Journals of Gerontology A Biological Sciences and Medical Sciences. 2015;70(8):924–935. doi: 10.1093/gerona/glu129. [PubMed] [Cross Ref]
7. Howitz K. T., Bitterman K. J., Cohen H. Y., et al. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature. 2003;425(6954):191–196. doi: 10.1038/nature01960. [PubMed] [Cross Ref]
8. Viswanathan M., Kim S. K., Berdichevsky A., Guarente L. A role for SIR-2.1 regulation of ER stress response genes in determining C. eleganslife span. Developmental Cell. 2005;9(5):605–615. doi: 10.1016/j.devcel.2005.09.017. [PubMed] [Cross Ref]
9. Wood J. G., Regina B., Lavu S., et al. Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature. 2004;430(7000):686–689. doi: 10.1038/nature02789. [PubMed] [Cross Ref]
10. Valenzano D. R., Terzibasi E., Genade T., Cattaneo A., Domenici L., Cellerino A. Resveratrol prolongs lifespan and retards the onset of age-related markers in a short-lived vertebrate. Current Biology. 2006;16(3):296–300. doi: 10.1016/j.cub.2005.12.038. [PubMed] [Cross Ref]
11. Pearson K. J., Baur J. A., Lewis K. N., et al. Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span. Cell Metabolism. 2008;8(2):157–168. doi: 10.1016/j.cmet.2008.06.011. [PMC free article] [PubMed] [Cross Ref]
12. Giovannelli L., Pitozzi V., Jacomelli M., et al. Protective effects of resveratrol against senescence-associated changes in cultured human fibroblasts. Journals of Gerontology A Biological Sciences and Medical Sciences. 2011;66(1):9–18. doi: 10.1093/gerona/glq161. [PubMed] [Cross Ref]
13. Demidenko Z. N., Blagosklonny M. V. At concentrations that inhibit mTOR, resveratrol suppresses cellular senescence. Cell Cycle. 2009;8(12):1901–1904. doi: 10.4161/cc.8.12.8810. [PubMed] [Cross Ref]
14. Ido Y., Duranton A., Lan F., Weikel K. A., Breton L., Ruderman N. B. Resveratrol prevents oxidative stress-induced senescence and proliferative dysfunction by activating the AMPK-FOXO3 cascade in cultured primary human keratinocytes. PLoS ONE. 2015;10(2) doi: 10.1371/journal.pone.0115341.e0115341 [PMC free article] [PubMed] [Cross Ref]
15. Bhullar K. S., Hubbard B. P. Lifespan and healthspan extension by resveratrol. Biochimica et Biophysica Acta. 2015;1852(6):1209–1218. doi: 10.1016/j.bbadis.2015.01.012. [PubMed] [Cross Ref]
16. Ota H., Akishita M., Eto M., Iijima K., Kaneki M., Ouchi Y. Sirt1 modulates premature senescence-like phenotype in human endothelial cells. Journal of Molecular and Cellular Cardiology. 2007;43(5):571–579. doi: 10.1016/j.yjmcc.2007.08.008. [PubMed] [Cross Ref]
17. Huang J., Gan Q., Han L., et al. SIRT1 overexpression antagonizes cellular senescence with activated ERK/S6k1 signaling in human diploid fibroblasts. PLoS ONE. 2008;3(3, article e1710) doi: 10.1371/journal.pone.0001710. [PMC free article] [PubMed] [Cross Ref]
18. Yamashita S., Ogawa K., Ikei T., Udono M., Fujiki T., Katakura Y. SIRT1 prevents replicative senescence of normal human umbilical cord fibroblast through potentiating the transcription of human telomerase reverse transcriptase gene. Biochemical and Biophysical Research Communications. 2012;417(1):630–634. doi: 10.1016/j.bbrc.2011.12.021. [PubMed] [Cross Ref]
19. Lu T., Tsai J., Chen Y., et al. Downregulation of Sirt1 as aging change in advanced heart failure. Journal of Biomedical Science. 2014;21(1, article no. 57) doi: 10.1186/1423-0127-21-57. [PMC free article] [PubMed] [Cross Ref]
20. Sasaki T., Maier B., Bartke A., Scrable H. Progressive loss of SIRT1 with cell cycle withdrawal. Aging Cell. 2006;5(5):413–422. doi: 10.1111/j.1474-9726.2006.00235.x. [PubMed] [Cross Ref]
21. Song Z., Liu Y., Hao B., et al. Ginsenoside Rb1 prevents H2O2-induced HUVEC senescence by stimulating sirtuin-1 pathway. PLoS ONE. 2014;9(11, article e112699) doi: 10.1371/journal.pone.0112699. [PMC free article] [PubMed] [Cross Ref]
22. Park S.-J., Ahmad F., Philp A., et al. Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases. Cell. 2012;148(3):421–433. doi: 10.1016/j.cell.2012.01.017. [PMC free article] [PubMed] [Cross Ref]
23. Xia L., Wang X. X., Hu X. S., et al. Resveratrol reduces endothelial progenitor cells senescence through augmentation of telomerase activity by Akt-dependent mechanisms. British Journal of Pharmacology. 2008;155(3):387–394. doi: 10.1038/bjp.2008.272. [PMC free article] [PubMed] [Cross Ref]
24. Csiszar A., Sosnowska D., Wang M., Lakatta E. G., Sonntag W. E., Ungvari Z. Age-associated proinflammatory secretory phenotype in vascular smooth muscle cells from the non-human primate macaca mulatta: reversal by resveratrol treatment. Journals of Gerontology - Series A Biological Sciences and Medical Sciences. 2012;67(8):811–820. doi: 10.1093/gerona/glr228. [PMC free article] [PubMed] [Cross Ref]
25. Putics Á., Végh E. M., Csermely P., Soti C. Resveratrol induces the heat-shock response and protects human cells from severe heat stress. Antioxidants and Redox Signaling. 2008;10(1):65–75. doi: 10.1089/ars.2007.1866. [PubMed] [Cross Ref]
26. Sato A., Okada M., Shibuya K., et al. Resveratrol promotes proteasome-dependent degradation of Nanog via p53 activation and induces differentiation of glioma stem cells. Stem Cell Research. 2013;11(1):601–610. doi: 10.1016/j.scr.2013.04.004. [PubMed] [Cross Ref]
27. Regitz C., Fitzenberger E., Mahn F. L., Dußling L. M., Wenzel U. Resveratrol reduces amyloid-beta (Aβ1–42)-induced paralysis through targeting proteostasis in an Alzheimer model of Caenorhabditis elegans. European Journal of Nutrition. 2016;55(2):741–747. doi: 10.1007/s00394-015-0894-1. [PubMed] [Cross Ref]
28. Duan W.-J., Liu F.-L., He R.-R., et al. Autophagy is involved in the effects of resveratrol on prevention of splenocyte apoptosis caused by oxidative stress in restrained mice. Molecular Nutrition and Food Research. 2013;57(7):1145–1157. doi: 10.1002/mnfr.201200662. [PubMed] [Cross Ref]
29. Suzuki M., Bartlett J. D. Sirtuin1 and autophagy protect cells from fluoride-induced cell stress. Biochimica et Biophysica Acta. 2014;1842(2):245–255. doi: 10.1016/j.bbadis.2013.11.023. [PMC free article] [PubMed] [Cross Ref]
30. Vichai V., Kirtikara K. Sulforhodamine B colorimetric assay for cytotoxicity screening. Nature Protocols. 2006;1(3):1112–1116. doi: 10.1038/nprot.2006.179. [PubMed] [Cross Ref]
31. Castro J. P., Ott C., Jung T., Grune T., Almeida H. Carbonylation of the cytoskeletal protein actin leads to aggregate formation. Free Radical Biology and Medicine. 2012;53(4):916–925. doi: 10.1016/j.freeradbiomed.2012.06.005. [PubMed] [Cross Ref]
32. López-Otín C., Blasco M. A., Partridge L., Serrano M., Kroemer G. XThe hallmarks of aging. Cell. 2013;153(6):1194–1217. doi: 10.1016/j.cell.2013.05.039. [PMC free article] [PubMed] [Cross Ref]
33. Silva E., Soares-Da-Silva P. Protein cytoskeleton and overexpression of Na+,K +-ATPase in opossum kidney cells. Journal of Cellular Physiology. 2009;221(2):318–324. doi: 10.1002/jcp.21853. [PubMed] [Cross Ref]
34. Baraibar M. A., Friguet B. Oxidative proteome modifications target specific cellular pathways during oxidative stress, cellular senescence and aging. Experimental Gerontology. 2013;48(7):620–625. doi: 10.1016/j.exger.2012.10.007. [PubMed] [Cross Ref]
35. Bollineni R. C., Hoffmann R., Fedorova M. Proteome-wide profiling of carbonylated proteins and carbonylation sites in HeLa cells under mild oxidative stress conditions. Free Radical Biology and Medicine. 2014;68:186–195. doi: 10.1016/j.freeradbiomed.2013.11.030. [PubMed] [Cross Ref]
36. Kirkin V., McEwan D. G., Novak I., Dikic I. A role for ubiquitin in selective autophagy. Molecular Cell. 2009;34(3):259–269. doi: 10.1016/j.molcel.2009.04.026. [PubMed] [Cross Ref]
37. Boilan E., Winant V., Dumortier E., et al. Role of p38MAPK and oxidative stress in copper-induced senescence. Age. 2013;35(6):2255–2271. doi: 10.1007/s11357-013-9521-3. [PMC free article] [PubMed] [Cross Ref]
38. Rusin M., Zajkowicz A., Butkiewicz D. Resveratrol induces senescence-like growth inhibition of U-2 OS cells associated with the instability of telomeric DNA and upregulation of BRCA1. Mechanisms of Ageing and Development. 2009;130(8):528–537. doi: 10.1016/j.mad.2009.06.005. [PubMed] [Cross Ref]
39. Gao Z., Xu M. S., Barnett T. L., Xu C. W. Resveratrol induces cellular senescence with attenuated mono-ubiquitination of histone H2B in glioma cells. Biochemical and Biophysical Research Communications. 2011;407(2):271–276. doi: 10.1016/j.bbrc.2011.02.008. [PubMed] [Cross Ref]
40. Luo H., Yang A., Schulte B. A., Wargovich M. J., Wang G. Y. Resveratrol induces premature senescence in lung cancer cells via ROS-mediated DNA damage. PLoS ONE. 2013;8(3) doi: 10.1371/journal.pone.0060065.e60065 [PMC free article] [PubMed] [Cross Ref]
41. Eren M. K., Kilincli A., Eren Ö. Resveratrol induced premature senescence is associated with DNA damage mediated SIRT1 and SIRT2 down-regulation. PLoS ONE. 2015;10(4) doi: 10.1371/journal.pone.0124837.e0124837 [PMC free article] [PubMed] [Cross Ref]
42. Pandey K. B., Rizvi S. I. Protective effect of resveratrol on formation of membrane protein carbonyls and lipid peroxidation in erythrocytes subjected to oxidative stress. Applied Physiology, Nutrition, and Metabolism. 2009;34(6):1093–1097. doi: 10.1139/h09-115. [PubMed] [Cross Ref]
43. Wojcik S. Crosstalk between autophagy and proteasome protein degradation systems: possible implications for cancer therapy. Folia Histochemica et Cytobiologica. 2013;51(4):249–264. doi: 10.5603/fhc.2013.0036. [PubMed] [Cross Ref]
44. Tanida I. Autophagy basics. Microbiology and Immunology. 2011;55(1):1–11. doi: 10.1111/j.1348-0421.2010.00271.x. [PubMed] [Cross Ref]
45. Lv X. C., Zhou H. Y. Resveratrol protects H9c2 embryonic rat heart derived cells from oxidative stress by inducing autophagy: role of p38 mitogen-activated protein kinase. Canadian Journal of Physiology and Pharmacology. 2012;90(5):655–662. doi: 10.1139/y2012-051. [PubMed] [Cross Ref]
46. Mizushima N., Yoshimori T., Levine B. Methods in mammalian autophagy research. Cell. 2010;140(3):313–326. doi: 10.1016/j.cell.2010.01.028. [PMC free article] [PubMed] [Cross Ref]
47. Ding Q., Dimayuga E., Martin S., et al. Characterization of chronic low-level proteasome inhibition on neural homeostasis. Journal of Neurochemistry. 2003;86(2):489–497. doi: 10.1046/j.1471-4159.2003.01885.x. [PubMed] [Cross Ref]

Articles from Oxidative Medicine and Cellular Longevity are provided here courtesy of Hindawi